Carter J. Barger

1.5k total citations
22 papers, 708 citations indexed

About

Carter J. Barger is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Carter J. Barger has authored 22 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Genetics. Recurrent topics in Carter J. Barger's work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers) and FOXO transcription factor regulation (5 papers). Carter J. Barger is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (5 papers) and FOXO transcription factor regulation (5 papers). Carter J. Barger collaborates with scholars based in United States, Canada and Germany. Carter J. Barger's co-authors include Adam R. Karpf, Linda Chee, Kunle Odunsi, Wa Zhang, Cassie Liu, David Klinkebiel, Petra A. Link, Austin Miller, Stacey N. Akers and Michael J. Higgins and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Carter J. Barger

22 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carter J. Barger United States 14 517 171 153 100 77 22 708
Nagendra K. Chaturvedi United States 18 482 0.9× 144 0.8× 148 1.0× 121 1.2× 85 1.1× 42 775
Rezina Arju United States 11 617 1.2× 254 1.5× 168 1.1× 136 1.4× 92 1.2× 16 933
Suresh Bugide United States 12 428 0.8× 196 1.1× 159 1.0× 128 1.3× 51 0.7× 21 618
Azin Sayad Canada 10 425 0.8× 214 1.3× 117 0.8× 142 1.4× 49 0.6× 21 651
Marta Sesé Spain 10 444 0.9× 173 1.0× 232 1.5× 86 0.9× 94 1.2× 18 742
Ali E. Yesilkanal United States 8 491 0.9× 146 0.9× 205 1.3× 73 0.7× 76 1.0× 10 733
Marisa Mariani United States 15 476 0.9× 249 1.5× 235 1.5× 61 0.6× 73 0.9× 24 758
Dorine Bellanger France 11 330 0.6× 201 1.2× 199 1.3× 103 1.0× 79 1.0× 15 586
Kirsten H. Edmiston United States 13 545 1.1× 185 1.1× 148 1.0× 72 0.7× 49 0.6× 21 798
Jessica J. Gierut United States 16 570 1.1× 285 1.7× 103 0.7× 53 0.5× 100 1.3× 23 767

Countries citing papers authored by Carter J. Barger

Since Specialization
Citations

This map shows the geographic impact of Carter J. Barger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carter J. Barger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carter J. Barger more than expected).

Fields of papers citing papers by Carter J. Barger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carter J. Barger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carter J. Barger. The network helps show where Carter J. Barger may publish in the future.

Co-authorship network of co-authors of Carter J. Barger

This figure shows the co-authorship network connecting the top 25 collaborators of Carter J. Barger. A scholar is included among the top collaborators of Carter J. Barger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carter J. Barger. Carter J. Barger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stevers, Nicholas, Carter J. Barger, Chibo Hong, et al.. (2025). The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible. Molecular Cell. 85(12). 2337–2354.e9. 1 indexed citations
2.
Minami, Noriaki, Donghyun Hong, Céline Taglang, et al.. (2023). Hyperpolarized δ-[1- 13C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma. Scientific Reports. 13(1). 5190–5190. 3 indexed citations
3.
Batsios, Georgios, Céline Taglang, Nicholas Stevers, et al.. (2022). Deuterium Metabolic Imaging Reports on TERT Expression and Early Response to Therapy in Cancer. Clinical Cancer Research. 28(16). 3526–3536. 25 indexed citations
4.
Barger, Carter J., Abigail K. Suwala, Katarzyna M. Soczek, et al.. (2022). Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer. Nature Communications. 13(1). 5430–5430. 13 indexed citations
5.
Barger, Carter J., Linda Chee, Kunle Odunsi, et al.. (2021). Co-regulation and function of FOXM1/RHNO1 bidirectional genes in cancer. eLife. 10. 21 indexed citations
6.
Liu, Cassie, Carter J. Barger, & Adam R. Karpf. (2021). FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer. Cancers. 13(12). 3065–3065. 57 indexed citations
7.
Barger, Carter J., et al.. (2020). Data-Driven Participant Recruitment: Findings from the Alzheimer's Disease Neuroimaging Initiative 3. The Journal of Prevention of Alzheimer s Disease. 7(2). 122–127. 4 indexed citations
8.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2020). Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11(25). 2462–2463. 3 indexed citations
9.
Zhang, Wa, David Klinkebiel, Carter J. Barger, et al.. (2020). Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability. Cancers. 12(3). 764–764. 46 indexed citations
10.
Pugacheva, Elena M., Carter J. Barger, Spencer R. Rosario, et al.. (2019). BORIS Expression in Ovarian Cancer Precursor Cells Alters the CTCF Cistrome and Enhances Invasiveness through GALNT14. Molecular Cancer Research. 17(10). 2051–2062. 22 indexed citations
11.
Li, Jing, Carter J. Barger, Adam R. Karpf, et al.. (2019). NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers. 11(8). 1119–1119. 5 indexed citations
12.
Kour, Smit, Sandeep Rana, Jacob I. Contreras, et al.. (2019). CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96(4). 419–429. 21 indexed citations
13.
Barger, Carter J., Wa Zhang, Ashok Sharma, et al.. (2018). Expression of the POTE gene family in human ovarian cancer. Scientific Reports. 8(1). 17136–17136. 23 indexed citations
14.
Barger, Carter J.. (2018). FOXM1 Expression and Contribution to Genomic Instability and Chemoresistance in High-Grade Serous Ovarian Cancer. Graduate Medical Education Research Journal. 1 indexed citations
15.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9(4). 5216–5232. 25 indexed citations
16.
Lum, Michelle A., et al.. (2016). Protein Kinase Cα (PKCα) Is Resistant to Long Term Desensitization/Down-regulation by Prolonged Diacylglycerol Stimulation. Journal of Biological Chemistry. 291(12). 6331–6346. 13 indexed citations
17.
Zhang, Wa, Carter J. Barger, Kevin H. Eng, et al.. (2016). PRAME expression and promoter hypomethylation in epithelial ovarian cancer. Oncotarget. 7(29). 45352–45369. 71 indexed citations
18.
Zhang, Wa, Carter J. Barger, Petra A. Link, et al.. (2015). DNA hypomethylation-mediated activation ofCancer/Testis Antigen 45(CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics. 10(8). 736–748. 50 indexed citations
19.
Barger, Carter J., Wa Zhang, Aimee Stablewski, et al.. (2015). Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. Oncotarget. 6(29). 27613–27627. 59 indexed citations
20.
Buckingham, Lela, L. Penfield Faber, Anthony Kim, et al.. (2009). PTEN, RASSF1 and DAPK site‐specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. International Journal of Cancer. 126(7). 1630–1639. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nagendra K. Chaturvedi Breakdown of academic impact, for papers by Rezina Arju Breakdown of academic impact, for papers by Suresh Bugide Breakdown of academic impact, for papers by Azin Sayad Breakdown of academic impact, for papers by Marta Sesé Breakdown of academic impact, for papers by Ali E. Yesilkanal Breakdown of academic impact, for papers by Marisa Mariani Breakdown of academic impact, for papers by Dorine Bellanger Breakdown of academic impact, for papers by Kirsten H. Edmiston Breakdown of academic impact, for papers by Jessica J. Gierut
Rankless by CCL
2026